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Abstract
Background: To develop services, healthcare professionals must make business cases to managerial bodies within
Hospital Trusts and if approved, to commissioning bodies. Patients with hip fracture are at high risk of subsequent
fracture. To prevent this, guidance recommends structuring fracture prevention services around coordinator based
models. These are known as Fracture Liaison Services (FLS).
Methods: 33 semi-structured qualitative interviews were conducted with healthcare professionals with experience
of making business cases for FLS. Data was analysed thematically.
Results: Challenges in the development of business cases included collecting all the relevant data and negotiating
compartmentalised budgets that impeded service development. Participants described communication and
cooperation between providers and commissioners as variable. They felt financial considerations were the most
important factor in funding decisions, while improved quality of care was less influential. Other factors included
national guidelines and political priorities. The personalities of clinicians championing services, and the clinical
interests of commissioners were seen to influence the decision-making process, suggesting that participants felt
that decisions were not always made on the basis of evidence-based care. Effective strategies included ways of
providing support, demonstrating potential cost effectiveness and improved quality of care. Using a range of
sources including audit data collected on the successful Glasgow FLS, and improving cooperation between
stakeholders was advocated. Participants felt that the work of commissioners and providers should be better
integrated and suggested strategies for doing this.
Conclusions: This study provides information to healthcare professionals about how best to develop business cases
for FLS. We conclude with recommendations on how to develop effective cases. These include using guidance such as
toolkits, aligning the aims of FLS with national priorities and benchmarking services against comparators. Introducing a
‘Local Champion’ to work alongside the service manager and establishing a multi-disciplinary working team would
facilitate communication between stakeholders. Involving commissioners in service design would help integrate the
roles of purchasers and providers.
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Background
Commissioning (purchasing) processes in the UK’s Na-
tional Health Service (NHS) are founded on a division
between purchasers and providers [1]. In April 2013, re-
sponsibility for the commissioning of services changed
from the Department of Health and local Primary Care
Trusts led by managers, to NHS England, an organisa-
tion overseeing 211 GP led local Clinical Commissioning
Groups [2]. Foundation Trusts are independent organi-
sations responsible for providing over half of NHS sec-
ondary care services operating in local regions. They are
contracted to deliver services commissioned by local
Clinical Commissioning Groups and NHS England, and
all NHS Trusts are in the process of becoming Foundation
Trusts [3]. Commissioning processes have been targeted
by the Department of Health as a means of safe-guarding
standards of care and driving quality improvements in the
NHS [4]. Core principles outlined by the NHS Commis-
sioning Board states funding decisions should be based on
the cost-effectiveness of the proposed service, clinical out-
comes and the strategic plans of the NHS Trust. Decisions
should therefore be made on the strength of the available
evidence and the robustness of the business cases [2].
Within the new commissioning structures all proposals
for new services must be made through submission of
business cases [2]. These are considered by managerial
bodies within the local NHS Trust, which include senior
clinicians and managers. If supported, then the case for a
new service is presented to their Clinical Commissioning
Groups for approval. Responsibility for developing busi-
ness cases rests with clinicians and operational service
managers. Finance managers develop budgets for new ser-
vices and patient representatives, clinicians and service
managers from other departments may also be involved in
case development.
Previous research exploring the day-to-day experiences of
commissioning in the UK has been largely focused on com-
missioners, highlighting experiences of those working
under the Primary Care Trusts [5–7] and to a lesser extent,
the newly formed Clinical Commissioning Groups [8, 9].
These have identified factors that inform commissioning
decisions, including cost-effectiveness [7, 10], clinical guide-
lines and benchmarking data [7] . They also suggest that
the relationships between stakeholders involved in the
commissioning process are variable [6, 11, 12]. More
recent research has also examined the attitudes of GP
providers towards the introduction of Clinical Commis-
sioning Groups, indicating that GPs are concerned that
they lack the capacity and capability to engage in
commissioning [13, 14]. However, with the exception of
Shaw et al. [15], who suggest that there are high levels
of integration between commissioners and providers in
commissioning processes, research exploring the expe-
riences of acute providers has been limited.
Hip fracture is an example of an important health
problem that necessitates specialised services. Each year
87,000 hip fractures occur in the UK [16] at a cost of
around £2.3 billion [17]. Hip fractures usually occur
when individuals with underlying osteoporosis fall [17],
and patients who have a hip fracture are at high risk of
further fragility fractures and premature death [18]. Ef-
fective management of these fractures can reduce the
risk of further fractures [16]. Guidance recommends
structuring fracture prevention services around a dedi-
cated coordinator who provides a link between all the
multi-disciplinary teams involved, an approach known as
a Fracture Liaison Service (FLS) [16]. The model pro-
posed by the Department of Health is one coordinated
by a nurse specialist with support from a lead clinician
in osteoporosis [19]. The efficacy of this model has been
supported by a number of studies [20]. Despite this,
fewer than 40 % of hospitals have established a FLS in
the UK [21]. In the new commissioning structures,
provision of any new services necessitates development
and approval of business cases. There is already some
support in place for clinicians and service managers who
wish to develop business cases for a FLS, including advice
about how to establish a dedicated multi-disciplinary team
to lead the case and business case templates [22, 23]. Al-
though practical, the advice is not based on an under-
standing of issues that clinicians and service managers
themselves see as relevant to the production of strong
business cases with good chance of success. Identifying
these has the potential to inform the development of fur-
ther guidance and recommendations for development of
business case specifically for FLS. More generally, under-
standing the views of clinicians and service managers in-
volved in the delivery of services of making business cases
provides us with valuable information about how new
commissioning processes are experienced by these groups.
The study aims to: a) explore the experiences of clini-
cians and service managers of developing and making busi-
ness cases for a FLS; b) identify factors that are seen to
inform the decision of managerial bodies to approve a FLS;
c) describe clinicians’ and service managers’ views about
the best ways of making business cases for this service.
Methods
Sample
This qualitative study took place in 11 acute hospitals
that receive hip fracture patients in a region of England,
as part of a larger study exploring hip fracture services
[24]. Clinicians and service managers involved in plan-
ning and delivering fracture prevention services were
approached about participation. Potential participants
were identified by a Clinical Lead Champion in Osteo-
porosis and purposively sampled to ensure inclusion of
professionals from all 11 hospitals.
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In three waves of recruitment, potential participants
were approached first by email then followed-up by fur-
ther email and telephone calls. Snowball sampling was
used to widen sampling [25], with participants suggesting
other individuals to contact. In total, 82 healthcare profes-
sionals were contacted and 43 agreed to take part in quali-
tative interviews. The remainder either declined or were
unavailable. Of these, 33 participants had experience of
making business cases for a FLS and it is these who are in-
cluded in our analysis. The sample size reflects inclusion
of a range of professionals from all hospitals, their avail-
ability and knowledge of business case development.
Rather than aiming to achieve data saturation [25] the
study sought to generate sufficient and adequate mater-
ial reflecting appropriate range of experiences [26].
Ethical approval
Ethical approval was provided by the Central University
Research Ethics Committee (CUREC) in 2012, reference
number MSD-IDREC-C1-2012-147. Written, informed
consent was provided by all participants prior to inter-
view. Each involved NHS Trust provided R&D approval
for the study.
Interview procedure
The qualitative researcher (SD) undertook face-to-face
interviews in 2013 lasting between 30 and 50 min. A
topic guide helped the researcher to explore participants’
experiences of making business cases for a FLS, factors
that they felt informed the decision of commissioners to
approve the new service and what they considered to be
the best strategies for making them. The interviewer
used methods such as ‘probing’ to help achieve depth in
the data [27]. Interviews were piloted with three partici-
pants in order to refine the topic guide and the three
pilot interviews are included in the dataset.
Data analysis
Interviews were audio-recorded, transcribed, anonymised
and imported into the data analysis software NVivo. Using
a thematic approach to analysis [28], transcripts were
coded and then these grouped to identify dominant
themes and subthemes. Emerging themes were compared
and contrasted with the data extracts and transcripts to
ensure interpretations reflected the data collected, with
memos to record thoughts and ideas as themes developed.
20 % of the interview transcripts were independently
coded by another member of the team (RG-H) and codes
discussed to arrive at a single code list [29]. To enable
cross-comparison, coded data were displayed on charts
using the framework approach to data organisation [30].
Identifying features have been removed from the data pre-
sented in Tables 1, 2 and 3.
Results
Characteristics of sample
The 33 participants comprised five fracture prevention
nurses, four orthogeriatricians, four geriatricians, two GP
osteoporosis specialists, three consultant trauma ortho-
paedic surgeons, six rheumatology consultants, two ortho-
paedic nurses, one trauma matron, one bone densitrometry
specialist and five service managers. Between one and five
participants were from each of the 11 hospitals. Clinicians
had spent between 1 ½ and 27 years working at the hospital
and had between 8 months and 43 years since qualification
in their current role. Service managers, by contrast, had
spent less time working at the hospital, a mean of 2 ¼ years,
and had between 2 and 6 years of experience. Of the 11
hospitals included in this study, seven had established a
FLS coordinated by a nurse specialist with support from a
clinical lead by 2013.
Experiences of making business cases for a FLS (Table 1)
Clinicians and service managers found the experience
challenging and a number of clinicians expressed frus-
tration. Clinicians and managers found the process of
constructing business cases time consuming and strug-
gled to find the capacity to do this whilst fulfilling clin-
ical commitments.
Approval processes were also described as ‘tedious’
and ‘incredibly cumbersome’. This was thought to be ex-
acerbated by rapid turnover of operational service man-
agers and senior managers within the Trusts that meant
progress was lost, in addition to multiple tiers of man-
agement with responsibility for approval.
Some clinicians felt more capable than others of mak-
ing business cases and understanding the approval pro-
cesses, based on their individual skillsets and levels of
training. A number of participants found it difficult to
collect all the relevant data required since quality was
often lacking. Others were unsure how to effectively
demonstrate improvements in care quality.
Table 1 Experiences of making business cases for an FLS
[Making business cases is a] total and utter brick wall… and after a while
you do lose the will to live. [Participant ID: 029]
I will never be able to write a good business case, because I can’t. I don’t
like doing them, I get bored, it’s not where my skills are so don’t ask me to
do it. [Participant ID: 009]
You constantly find you’ve got to go digging around for statistics. You’re
trying to find numbers from data that isn’t collected… [it’s] all done on
percentages and sort of guesswork. [Participant ID: 008]
If you start getting into areas of complexity, so frailty complexity, where
you get different services crossing: whose budget is it? It’s harder to cost
them… just things like this don’t fit into categories. [Participant ID: 007]
[The service manager's] priorities are dependent on their interests.
[Participant ID: 030]We felt that we were setting up and driving towards
an improved Hip Fracture Service… but we were doing it without the
support of our management. [Participant ID: 038]
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Compartmentalisation of budgets within individual hos-
pital departments was seen as a barrier to service develop-
ment. Participants described lack of agreement about
which Department should be responsible for funding a
service, which was linked to the involvement of multi-
disciplinary teams in the prevention of secondary frac-
tures, both within the hospital and community care [16].
Participants recognised the value of effective communi-
cation and cooperation between a range of stakeholders
involved in the commissioning process, but described this
as variable. Within the multi-disciplinary team, partici-
pants identified examples of effective communication but
had also encountered colleagues that were more ‘resistant
to change’. One participant attributed this to the cynicism
surrounding the process. Although participants described
examples of successful co-working between clinicians and
operational service managers, some service managers
wanted more help from clinicians. A number of clinicians
also found it difficult that service managers whom they
worked with did not seem to be interested in service de-
velopment. In general there was a view that communica-
tion with commissioners and providers (including Trust
Managers) was variable and could be improved.
Views about FLS approval (Table 2)
Participants discussed their views about factors considered
in commissioning processes. They thought financial consid-
erations were most important and that there was pressure
to generate short-term cost savings. There was concern that
this presented a challenge for fracture prevention services,
which tend to generate longer-term savings.
Clinicians tended to think quality of care was afforded
low priority in decision-making processes, while service
managers thought that quality of care was a consideration.
Participants thought that national guidelines and political
priorities were key factors in decisions about services, and
some expressed dissatisfaction with the importance
afforded to these. Participants felt commissioners were
less likely to approve FLS than other services, since osteo-
porosis was viewed as a low national priority and because
there was a belief that osteoporosis should be managed in
primary care, reflecting a more general shift of resources
into primary care [31].
Clinicians thought that funding tended to be chan-
nelled into high profile ‘failing’ services that had poor
clinical outcomes and audit results. Participants from
one hospital were frustrated that their service had to de-
teriorate before they received funding for a FLS.
The ambition and personality of ‘local champions’, the
clinician involved in leading the business case [32], was
also seen to impact on whether the service was ap-
proved. Participants also felt the clinical interests of GP
commissioners influenced the decision-making process
since they were more likely to approve services that
reflected their priorities. As a result, there was a sugges-
tion that funding decisions were not always based on
principles of evidence based healthcare.
Best ways of making a business case for an FLS (Table 3)
Participants described ways they felt the challenges of busi-
ness case development could be addressed. They identified
the potential value of training courses, templates or ‘toolk-
its’. Other suggestions for enhancing support included the
introduction of mentorship schemes with those who had
successfully set up services, or establishing a network of
mutually supportive service managers and clinicians.
Table 2 Factors seen to determine whether an FLS is approved
The powers that be don’t want to put the money into it because you’re not
going to see an instant result. [Participant ID: 015]
It has kind of lost the quality of care a little bit… quality doesn’t pay the
bills unfortunately [Participant ID: 023]
What tends to happen in healthcare is that you get certain things that
become a certain flavour of the month. So lets look at this, this and this
disease. Right what are we going to do in hospitals, whose doing that,
right we think this is a priority would you like to do something in this area.
[Participant ID: 026]
I think it often comes down to the individual people who are doing it…
you’ve got [a local champion in another hospital] sort of waving his little
flag and everybody listens. Well if you hadn’t have had a him you may not
have had that service. [Participant ID: 023]
He who shouts loudest gets most [Participant ID: 001]
We have this problem with commissioning the local General Practitioners, if
you have a clinical lead who has a strong interest in dementia services then
there will be lots of money put into dementia services. [Participant ID: 001]
If the chairman of a CCG had had a mother with a hip fracture (laughs) that
CCG, I can tell you, someone would push it through. [Participant ID: 008]
Table 3 Best ways of making a business case for a FLS
You can use other [services as] comparators and the USA seems to be
quite a good thing to beat doctors with at the moment so if you look at
outcome in the best centres compared to the average centres, which is
quite a good… we do this but [another Trust] do this, what’s the
difference? Well they’ve got 15 Fracture Liaison Nurses and everyone doing
this… [the Trust] tend to benchmark things across local groups but if
you’ve got national comparators those are quite good. [Participant ID: 021]
I think patients’ voice can have more power, especially if we are looking at
situations where we feel that patients may be at risk and I think that
obviously helps to drive the changes as well. [Participant ID: 012]
You also need to get allies on side who will help you and support you…
people who are key, for example, [a GP], she wasn’t involved in
commissioning or anything but she is very well respected in her field
[Participant ID: 004]
I think the managers are too separate and it should be more embedded
and integrated so that we work together and we come up with clinical
designs and models, they tell us we’re stupid anspending too much money,
and then we work it out and come up with a compromise for it.
[Participant ID: 009]
It’s through no fault of anyone’s but these are human organisations and
you’ve got to engage with these things on a human level… It’s much easier
to say no to someone who you’ve been saying no repeatedly to for the last
five years and where you’re not regularly seeing them. [Participant ID: 024]
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Participants suggested using empirical evidence in
business cases to demonstrate the efficacy of different
models of care. For instance, some advocated citing re-
search on the Glasgow FLS, a service that has contrib-
uted to a 7.3 % reduction in hip fractures in the city
over 10 years, compared to rise of 17 % across England
[19]. In light of participants’ view that osteoporosis was
often afforded low priority, two suggested that the status
of the service could be improved if the business case
emphasised how the aims of the FLS supported national
health priorities identified by the Department of Health
such as dementia [33].
Participants also highlighted the use of practical
sources of evidence such as outcomes data, like the Hos-
pital Episodes Statistics [34], to make cost effectiveness
calculations. Benchmarking the service using clinical
outcomes data against local and national comparators
was advocated. Some participants suggested involving
the public, either through patient satisfaction question-
naires or patient representatives, although few had done
so in practice.
To develop effective communication and cooperation,
participants advocated contacting all those involved in
developing the case early on to garner support and en-
sure the case was viable. Service managers felt that clini-
cians had an important role in canvassing the support of
their colleagues and one felt that regular meetings with
the Clinical Lead had already helped them to work to-
gether successfully. Building networks with the ‘right’
people, such as prominent clinicians who could support
the case, was described as a helpful way to achieve re-
spect from commissioners.
Participants thought that the roles of purchasers and
providers should be more closely integrated. Strategies in-
cluded approaching managerial bodies early in the process
to help establish their priorities and give them ‘advanced
warning’ of funding requests. Developing plans with Clin-
ical Commissioning Groups and informal networking were
also suggested.
Discussion
This study has identified and explored clinicians’ and
managers’ experiences of making business cases for FLS,
factors that are seen to determine whether the case is
approved and views on the most effective ways of mak-
ing these business cases. Participants found the process
of business case development to be time consuming and
frustrating, with collection of relevant data a challenge.
Participants thought that competence and understanding
of processes varied. The current funding allocation
mechanisms within the NHS were seen to make funding
a service across several disciplines harder to achieve.
Communication and cooperation between the stake-
holders involved in these processes, including providers
and commissioners, was seen as important but not al-
ways optimal. Participants described their views about
factors that influenced funding approval. They thought
financial considerations were afforded most importance,
and other factors included national guidelines and polit-
ical priorities. Clinicians thought improvements to care
quality were not a priority, but this view was not echoed
by managers. The personality and drive of local clinical
champions, and clinical interests of commissioners were
also seen to influence funding decisions and that as a re-
sult, decisions were not always based on the principles
of evidence based healthcare. Finally, participants identi-
fied ways in which business case development could be
supported. Suggestions included provision of training
courses and the introduction of mentorship schemes.
The importance of using empirical evidence such as
clinical guidelines and academic research as well as prac-
tical sources of evidence was highlighted. Strategies for
improving communication and cooperation between
stakeholders were also suggested.
Previous studies exploring providers’ experiences of
commissioning under the Primary Care Trusts found the
processes time consuming [15] and collecting all rele-
vant data difficult since available data was often of low
quality [15, 35]. The challenge of managing the relation-
ship between purchasers and providers has also previ-
ously been highlighted [11, 12, 36]. Although one study
found that there were high levels of cooperation [15],
others, as with ours, concluded that the relational as-
pects of commissioning could be improved [11, 12]. Our
study also succeeds in communicating the lack of confi-
dence of providers in navigating these processes and the
difficulty of funding services across several disciplines.
Factors that participants identified as informing commis-
sioning decisions reflect guidance issued by the NHS
Commissioning Board [37]. However, participants felt that
commissioners placed different relative emphasis on these
factors. Participants also questioned the objectivity of the
Clinical Commissioning Groups, suggesting the personality
of local clinical champions and the clinical interests of
commissioners impacted on decision-making. The poten-
tial influence of clinical interests supports concerns raised
by participants in previous studies [35, 38]. Although the
introduction of GP-led Clinical Commissioning Groups
were intended to involve clinicians in making funding deci-
sions then [2], this suggests that there may be a disconnect
between the views of GP commissioners and providers.
Strategies identified to support development of effect-
ive business cases support previous work.
Using multiple sources of evidence is advocated in a
business case template developed to support the imple-
mentation of a FLS. This recommends calculating the fi-
nancial burden of fragility fractures for the Hospital
alongside potential savings, referencing the economic
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burden of secondary fractures in the UK, and citing na-
tional policy and research on existing models of care
[22]. The value of using multiple evidence bases is sup-
ported by findings from other studies [10, 15]. Ensuring
that effective communication exists between all service
providers, including those in secondary and primary
care, has also been highlighted [23]. There is a strong
emphasis on the need to develop multi-disciplinary
working groups when developing a case, with a Clinical
Lead to guide it [22, 23]. These recommendations are
supported by the Fracture Liaison Implementation
Programme (FLIP), a new supportive tool for designing
business cases for FLS [39].
In accordance with this research, participants in previ-
ous studies have suggested that better integration be-
tween commissioners and providers may help to
facilitate service development [15]. To do this, guidance
advises contacting commissioners from the outset to es-
tablish a funding remit and discuss the potential scale of
the service [23]. Another strategy may be to introduce
representatives from commissioning bodies into these
multi-disciplinary groups [22]. In addition to these fac-
tors, other recommendations include the introduction of
protected time for Lead Clinicians to work on business
cases [22]. This could address the lack of time many par-
ticipants identified as a barrier to case development.
The use of qualitative methods enabled us to under-
take a detailed exploration of the opinions and experi-
ences of professionals. Robust analysis processes provide
confidence that the data has been thoroughly explored,
for instance we used double coding and team work to
discuss results during the analysis process [40]. The
study aimed to include participants with diverse and
relevant experiences rather than to achieve data satur-
ation; inclusion of 33 participants with experience of
business case development is a strength. However, we
were only able to include five service managers and al-
though we tried to include many more we found it hard
to recruit this group, which limits our ability to draw
firm conclusions about their views. Despite this, the in-
clusion of 28 clinicians in this study is of great value be-
cause healthcare professionals are increasingly expected
to develop business cases for services within the NHS.
Since this work forms part of a larger interview study, it
is unlikely participants self-selected on the basis of their
experiences of making business cases, and we are rela-
tively confident that the findings are not unduly influ-
enced by selection bias. We found that there was little
difference between the views of participants who had
successfully established a service and those who had not.
As a result, we do not distinguish between the two
groups in our analysis. The study elicited verbal descrip-
tions of the experience of making business cases, which
are recollections of process. An alternative study design
would have been to shadow professionals though the
process, but this might have been difficult for reasons of
practicality and resource. For this reason we chose inter-
views as a way of efficiently collecting data, and used face-
to-face interviews to enable rapport between interviewer
and participants. The study is also limited as only one re-
gion was included. However, the homogeneity of experi-
ences and the inclusion of all NHS Trusts in that region
indicate that it is likely that experiences described resonate
with those in other areas and are transferable [25].
Further research could examine the experiences of pri-
mary care professionals in developing cases for these ser-
vices, because primary care has an important role in
preventing secondary fractures [16]. In addition, as FLS is
a global phenomenon, it may be of use to explore experi-
ences of commissioning services in other care settings.
Doing so would provide professionals with information on
how to make effectives cases in other contexts.
Conclusions
The study provides information to healthcare profes-
sionals and service managers about how best to develop
business cases for a FLS in the future. Based on these find-
ings and in light of previous studies, we have generated a
set of recommendations for developing business cases
(Table 4). These findings may be of use for stakeholders
involved in making business cases for other conditions.
Table 4 Recommendations for developing business cases for FLS
1. Using all available support. This includes national toolkits for FLS outlined
by the IOF Capture the Fracture Initiative [41], the Fracture Liaison
Implementation Programme (FLIP) [39], the Osteoporosis Service
Development model [42] and training courses [22]. More general
guidance issued by Clinical Commissioning Groups may also be used [43].
2. Using empirical evidence such as academic research to demonstrate
the efficacy of FLS alongside clinical guidelines. Research identifying
outcomes of the Glasgow FLS may be of use here [44]. Aligning the
aims of the FLS with national priorities such as dementia could also
be considered.
3. Using evidence such as outcomes data from the Hospital Episode
Statistics [34], to make cost effectiveness calculations.
4. Benchmarking the service against local and national comparators
using audit data.
5. Identifying a ‘Local Champion’ [22], generally the Lead Clinician within
the Department, to work alongside the service manager. This clinician
has an important role in providing clinical input and obtaining support
from clinicians working both within and outside of the team.
6. Developing effective communication and cooperation with
stakeholders working both inside and outside of the Department
by establishing a multi-disciplinary working team [22]. Service
managers have a responsibility to communicate with managers
working in related areas.
7. Approaching managerial bodies and Commissioners early in the
process to establish their priorities and working with them to develop
the service if possible. Informal networking may be of use.
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